We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ELTP Elite Pharmaceuticals Inc (QB)

-0.00652 (-4.49%)
Last Updated: 11:17:28
Delayed by 15 minutes


Draw Mode:

Volume 1,350,770
Bid Price 0.137
Ask Price 0.1385
News -
Day High 0.145


52 Week Range


Day Low 0.13
Share Name Share Symbol Market Stock Type
Elite Pharmaceuticals Inc (QB) ELTP OTCMarkets Common Stock
  Price Change Price Change % Share Price Last Trade
-0.006515 -4.49% 0.138485 11:17:28
Open Price Low Price High Price Close Price Previous Close
0.14395 0.13 0.145 0.145
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
136 1,350,770 US$ 0.139132 US$ 187,936 - 0.0269 - 0.17
Last Trade Type Quantity Price Currency
11:17:28 1,600 US$ 0.138485 USD

Elite Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
141.95M 1.01B 705.48M 34.16M 3.56M 0.00 40.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Elite Pharmaceuticals (QB) News

Date Time Source News Article
11/27/202318:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/27/202317:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/27/202317:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/16/202306:32InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with..
9/25/202315:15Edgar (US Regulatory)Form 8-K - Current report
9/07/202315:05Edgar (US Regulatory)Form 8-K - Current report
8/14/202316:30Edgar (US Regulatory)Form 8-K - Current report
7/31/202315:20Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
7/17/202315:15Edgar (US Regulatory)Form 8-K - Current report
6/29/202316:15Edgar (US Regulatory)Form 8-K - Current report
6/29/202315:43Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ELTP Message Board. Create One! See More Posts on ELTP Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1550.160750.130.1524441,488,477-0.01652-10.65%
1 Month0.1170.170.100.14221821,560,1950.0214918.36%
3 Months0.08990.170.056050.12231221,248,9650.0485954.04%
6 Months0.0350.170.03010.09511091,179,6280.10349295.67%
1 Year0.0390.170.02690.0815514761,7350.09949255.09%
3 Years0.0480.170.0230.0598752771,9330.09049188.51%
5 Years0.08020.170.0230.0680083781,0960.0582972.67%

Elite Pharmaceuticals (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |